May 18
|
Rite Aid to Sell Majority of U.S. Pharmacy Operations to Rivals, Including CVS Health Corporation (CVS)
|
May 16
|
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
|
May 16
|
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
|
May 16
|
CVS Bids on Rite Aid Stores in Northwest US and Patient Data
|
May 16
|
Here's Why CVS Health (CVS) Looks Ripe for Bottom Fishing
|
May 16
|
Update: Market Chatter: CVS Bids for Rite Aid Stores, Patient Data in Pacific Northwest
|
May 16
|
For this CVS Health developer, making tech more accessible is personal
|
May 16
|
Rite Aid sells upwards of 1,000 stores to CVS, Walgreens, others
|
May 15
|
S&P 500 Rises as Fed-Cut Bets Sink Treasury Yields: Markets Wrap
|
May 15
|
Rite Aid to sell 1,000 pharmacy assets to CVS, Walgreens and others
|
May 15
|
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
|
May 15
|
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
|
May 15
|
5 Low Price-to-Book Value Stocks to Buy in May
|
May 14
|
CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy Innovation
|
May 14
|
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?
|
May 14
|
Why the UnitedHealth leadership shake-up is giving Wall Street the chills
|
May 14
|
Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna
|
May 14
|
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer
|
May 14
|
Why CVS Health Corporation (CVS) Declined on Tuesday
|
May 14
|
Why UnitedHealth’s Blowup May Be More Isolated Than Investors Think
|